Cited by 438Antifungal resistance and susceptibilityFungal Infections and StudiesOcular Infections and Treatments

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Excess Mortality, Hospital Stay, and Cost Due to Candidemia: A Case-Control Study Using Data From Population-Based Candidemia Surveillance

Morgan, Juliette, Meltzer, Martin I., Plikaytis, Brian D., Sofair, Andre N., Huie-White, Sharon, Wilcox, Steven, Harrison, Lee H., Seaberg, Eric C., Hajjeh, Rana A., Teutsch, Steven M.·2005·Infection Control & Hospital Epidemiology

DOI 10.1086/502581

Open this paper in CoChat — free account

Abstract

Objective: To determine the mortality, hospital stay, and total hospital charges and cost of hospitalization attributable to candidemia by comparing patients with candidemia with control-patients who have otherwise similar illnesses. Prior studies lack broad patient and hospital representation or cost-related information that accurately reflects current medical practices. Design: Our case-control study included case-patients with candidemia and their cost-related data, ascertained from laboratory-based candidemia surveillance conducted among all residents of Connecticut and Baltimore and Baltimore County, Maryland, during 1998 to 2000. Control-patients were matched on age, hospital type, admission year, discharge diagnoses, and duration of hospitalization prior to candidemia onset. Results: We identified 214 and 529 sets of matched case-patients and control-patients from the two locations, respectively. Mortality attributable to candidemia ranged between 19% and 24%. On multivariable analysis, candidemia was associated with mortality (OR, 5.3 for Connecticut and 8.5 for Baltimore and Baltimore County;P< .05), whereas receiving adequate treatment was protective (OR, 0.5 and 0.4 for the two locations, respectively;P< .05). Candidemia itself did not increase the total hospital charges and cost of hospitalization; when treatment status was accounted for, having received adequate treatment for candidemia significantly increased the total hospital charges and cost of hospitalization ($6,000 to $29,000 and $3,000 to $22,000, respectively) and the length of stay (3 to 13 days). Conclusion: Our findings underscore the burden of candidemia, particularly regarding the risk of death, length of hospitalization, and cost associated with treatment (Infect Control Hosp Epidemiol 2005;26:540-547).

Integrity signals

Registry

Crossref · 10.1086/502581

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440
Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387
Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality
Pittet, D. (1994) · JAMA · doi:10.1001/jama.271.20.1598 · Cited by 1,354
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Beck‐Sagué, C. M., Jarvis, W. R., & System, N. N. I. S. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Nosocomial Bloodstream Infection in Critically III Patients
Pittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 946
Hospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831
Secular Trend of Hospital‐Acquired Candidemia among Intensive Care Unit Patients in the United States during 1989–1999
Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Self-citation
Epidemiology of Nosocomial Fungal Infections, with Emphasis on Candida Species
Jarvis, W. R. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.6.1526 · Cited by 636
Trends in Infectious Diseases Mortality in the United States
Pinner, R. W. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530270029027 · Cited by 487

Flagged first, then by citations

Show all 26 references

Research works printed but not linked: 5

Haddix, 2003, Prevention Effectiveness, 53
Consumer Price Index
ChimeData Program
Health Services Cost Review
10.1001/archinte.1995.00430110089009 · DOI · Paper page

Sorted by citations

Items 101–200 of 438

Epithelial hypoxia maintains colonization resistance against Candida albicans
Savage, H. P., Bays, D. J., Tiffany, C. R., Gonzalez, M. A. F., Bejarano, E. J., de Carvalho, T. P., Luo, Z. L., Masson, H. L. P., Nguyen, H., Santos, R. L., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.05.008 · Cited by 59
Bench-to-bedside review: Therapeutic management of invasive candidiasis in the intensive care unit
Bassetti, M., Mikulska, M., & Viscoli, C. (2010) · Critical Care · doi:10.1186/cc9239 · Cited by 57
Photodynamic antimicrobial chemotherapy (PACT) inhibits biofilm formation by Candida albicans, increasing both ROS production and membrane permeability
Rosseti, I. B., Chagas, L. R., & Costa, M. S. (2013) · Lasers in Medical Science · doi:10.1007/s10103-013-1473-4 · Cited by 56
Interactions between Candida albicans and the resident microbiota
Li, H., Miao, M., Jia, C., Cao, Y.-B., Yan, T., Jiang, Y., & Yang, F. J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.930495 · Cited by 63
The human gut microbiome in health and disease: time for a new chapter?
Lee, J., Bays, D. J., Savage, H. P., & Bäumler, A. J. (2024) · Infection and Immunity · doi:10.1128/iai.00302-24 · Cited by 62
Is the incidence of candidemia caused byCandida glabrataincreasing in Brazil? Five-year surveillance ofCandidabloodstream infection in a university reference hospital in southeast Brazil
Moretti, M. L., Trabasso, P., Lyra, L., Fagnani, R., Resende, M. R., Cardoso, L. G. D. O., & Schreiber, A. Z. (2012) · Medical Mycology · doi:10.3109/13693786.2012.708107 · Cited by 58
Epidemiology of Community‐Onset Candidemia in Connecticut and Maryland
Sofair, A. N., Lyon, G. M., Huie‐White, S., Reiss, E., Harrison, L. H., Sanza, L. T., Arthington, B. A., & Fridkin, S. K. (2006) · Clinical Infectious Diseases · doi:10.1086/504807 · Cited by 55
Self-citation
The Candida albicans ENO1 gene encodes a transglutaminase involved in growth, cell division, morphogenesis, and osmotic protection
Reyna‐Beltrán, E., Iranzo, M., Calderón-González, K. G., Mondragón‐Flores, R., Labra‐Barrios, M. L., Mormeneo, S., & Luna‐Arias, J. P. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.810440 · Cited by 54
The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor—Active Surveillance in Selected Sites, United States, 2014–2017
Zhang, A. Y., Shrum, S., Williams, S., Petnic, S., Nadle, J., Johnston, H., Barter, D., Vonbank, B., Bonner, L., Hollick, R., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1061 · Cited by 54
Self-citation
Antifungal activity of the honey flavonoid extract against Candida albicans
Candiracci, M., Citterio, B., & Piatti, E. (2011) · Food Chemistry · doi:10.1016/j.foodchem.2011.09.012 · Cited by 52
Risk factors predicting Candida infective endocarditis in patients with candidemia
Foong, K. S., Sung, A., Burnham, J. P., Kronen, R., Lian, Q., Zetina, A. S., Hsueh, K., Lin, C., Powderly, W. G., & Spec, A. (2019) · Medical Mycology · doi:10.1093/mmy/myz104 · Cited by 55
The photodynamic effect of methylene blue and toluidine blue on Candida albicans is dependent on medium conditions
Carvalho, G. G., Felipe, M. P., & Costa, M. S. (2009) · The Journal of Microbiology · doi:10.1007/s12275-009-0059-0 · Cited by 51
Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?
Soulountsi, V., Schizodimos, T., & Kotoulas, S. (2021) · Infection · doi:10.1007/s15010-021-01640-7 · Cited by 52
Breakthrough candidaemia in the era of broad-spectrum antifungal therapies
Cuervo, G., Garcia-Vidal, C., Nucci, M., Puchades, F., Fernández-Ruiz, M., Obed, M., Manzur, A., Gudiol, C., Pemán, J., Aguado, J. M., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.09.029 · Cited by 49
Impact of invasive fungal infection on outcomes of severe sepsis: a multicenter matched cohort study in critically ill surgical patients
Xie, G.-H., Fang, X., Fang, Q., Wu, X.-M., Jin, Y., Wang, J., Guo, Q.-L., Gu, M.-N., Xu, Q.-P., Wang, D., et al. (2008) · Critical Care · doi:10.1186/cc6766 · Cited by 49
Candida albicans VMA3 Is Necessary for V-ATPase Assembly and Function and Contributes to Secretion and Filamentation
Rane, H. S., Bernardo, S. M., Raines, S. M., Binder, J., Parra, K. J., & Lee, S. A. (2013) · Eukaryotic Cell · doi:10.1128/ec.00118-13 · Cited by 49
Central venous catheter (CVC) removal for patients of all ages with candidaemia
Janum, S., & Afshari, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011195.pub2 · Cited by 50
Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital
Girão, E. S., Levin, A. S., Basso, M., Gobara, S., Gomes, L. B., Medeiros, E. A., & Costa, S. F. (2008) · Medical Mycology · doi:10.1080/13693780802004996 · Cited by 48
Infections and Extracorporeal Membrane Oxygenation
Haneke, F., Schildhauer, T. A., Schlebes, A. D., Strauch, J. T., & Swol, J. (2015) · ASAIO Journal · doi:10.1097/mat.0000000000000308 · Cited by 47
Length of stay and charges associated with health care-acquired bloodstream infections
Rawajfah, O. A., Hewitt, J. B., Stetzer, F., & Cheema, J. (2011) · American Journal of Infection Control · doi:10.1016/j.ajic.2011.03.014 · Cited by 46
Epidemiology and Evolution of Fungal Pathogens in Plants and Animals
Gladieux, P., Byrnes, E. J., Aguileta, G., Fisher, M. C., Heitman, J., & Giraud, T. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-384890-1.00004-2 · Cited by 46
The role ofCandida albicansAP-1 protein against host derived ROS in in vivo models of infection
Jain, C. M., Pastor, K., Gonzalez, A. Y., Lorenz, M. C., & Rao, R. P. (2013) · Virulence · doi:10.4161/viru.22700 · Cited by 46
Diphenyl diselenide (PhSe)2 inhibits biofilm formation by Candida albicans, increasing both ROS production and membrane permeability
Rosseti, I. B., da Rocha, J. B. T., & Costa, M. S. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.08.001 · Cited by 45
Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey.
Kuzucu, Ç., Durmaz, R., Otlu, B., Aktaş, E., Gülcan, H., & Çizmeci, Z. (2008) · PubMed · Cited by 43
The Epidemiology of Neonatal and Pediatric Candidemia in England and Wales, 2000–2009
Oeser, C., Lamagni, T. L., Heath, P. T., Sharland, M., & Ladhani, S. N. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318275612e · Cited by 44
Candidemia on presentation to the hospital: development and validation of a risk score
Shorr, A. F., Tabak, Y. P., Johannes, R. S., Sun, X., Spalding, J. R., & Kollef, M. H. (2009) · Critical Care · doi:10.1186/cc8110 · Cited by 43
Usefulness of EQUAL Candida Score for predicting outcomes in patients with candidaemia: a retrospective cohort study
Huang, H., Lu, P., Wang, Y., Chen, T., Chang, K., & Lin, S. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.01.029 · Cited by 41
Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?
Zaragoza, R., Perman, J., Salavert, M., Viudes, Solé, A., Jarque, I., Cantón, R., Monte‐Boquet, E., & Romá, E. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3994 · Cited by 42
Candida catheter-related bloodstream infection in patients on home parenteral nutrition - Rates, risk factors, outcomes, and management
Phua, A. I.-H., Hon, K. Y., Holt, A. W., O’Callaghan, M., & Bihari, S. (2019) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2019.03.007 · Cited by 39
Is Candida colonization of central vascular catheters in non-candidemic, non-neutropenic patients an indication for antifungals?
Pérez‐Parra, A., Muñóz, P., Guinea, J., Martín‐Rabadán, P., Guembe, M., & Bouza, E. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1431-6 · Cited by 39
Rapid redistribution of phosphatidylinositol-(4,5)-bisphosphate and septins during the Candida albicans response to caspofungin
Badrane, H., Nguyen, M. H., Blankenship, J. R., Cheng, S., Hao, B., Mitchell, A. P., & Clancy, C. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00112-12 · Cited by 38
The Epidemiology of Candida Colonization and Invasive Candidiasis in a Surgical Intensive Care Unit Where Fluconazole Prophylaxis is Utilized
Magill, S. S., Swoboda, S. M., Shields, C. E., Colantuoni, E., Fothergill, A. W., Merz, W. G., Lipsett, P. A., & Hendrix, C. W. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e31819ed914 · Cited by 38
Invasive candidiasis and candidemia: from current opinions to future perspectives
Rüping, M., Vehreschild, J. J., & Cornely, O. A. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902911440 · Cited by 39
Procalcitonin as a marker of Candida species detection by blood culture and polymerase chain reaction in septic patients
Cortegiani, A., Russotto, V., Montalto, F. I., Foresta, G., Accurso, G., Palmeri, C., Raineri, S. M., & Giarratano, A. (2014) · BMC Anesthesiology · doi:10.1186/1471-2253-14-9 · Cited by 38
Development and validation of a clinical prediction rule for candidemia in hospitalized patients with severe sepsis and septic shock
Guillamet, C. V., Vazquez, R., Micek, S. T., Ursu, O., & Kollef, M. H. (2015) · Journal of Critical Care · doi:10.1016/j.jcrc.2015.03.010 · Cited by 37
Histatin 5-Spermidine Conjugates Have Enhanced Fungicidal Activity and Efficacy as a Topical Therapeutic for Oral Candidiasis
Tati, S., Li, R., Puri, S., Kumar, R., Davidow, P., & Edgerton, M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01851-13 · Cited by 36
Time to positivity of blood culture can predict different Candida species instead of pathogen concentration in candidemia
Huang, L., Zhang, Y. Y., & Sun, L. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1826-8 · Cited by 36
Clinical practice guidelines for the management of invasive Candida infections in adults in the Middle East region: Expert panel recommendations
Alothman, A. F., Al-Musawi, T., Al-Abdely, H. M., Salman, J. A., Almaslamani, M., Yared, N., Butt, A. A., Raghubir, N., Morsi, W. E., & Althaqafi, A. (2013) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2013.08.002 · Cited by 36
Usefulness of guideline recommendations for prognosis in patients with candidemia
Cuervo, G., García‐Vidal, C., Puig‐Asensio, M., Merino, P., Vena, A., Martín‐Peña, A., Montejo, J. M., Gaitán, A. C. R., Lázaro-Perona, F., Fortün, J., et al. (2018) · Medical Mycology · doi:10.1093/mmy/myy118 · Cited by 36
Anticandidal activity of synthetic peptides: Mechanism of action revealed by scanning electron and fluorescence microscopies and synergism effect with nystatin
Lima, P. G., Souza, P. F. N., Freitas, C. D. T., Oliveira, J. T. A., Dias, L. P., Neto, J. X. S., Vasconcelos, I. M., Lopes, J. L. D. S., & Sousa, D. O. B. (2020) · Journal of Peptide Science · doi:10.1002/psc.3249 · Cited by 39
Lactoferrin, chitosan and Melaleuca alternifolia —natural products that show promise in candidiasis treatment
Felipe, L. D. O., Júnior, W. F. D. S., de Araújo, K. C., & Fabrino, D. L. (2017) · Brazilian Journal of Microbiology · doi:10.1016/j.bjm.2017.05.008 · Cited by 35
Epidemiology and prognostic factors of candidemia in elderly patients
Tang, H., Liu, W., Lin, H.-L., & Lai, C. (2014) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12329 · Cited by 35
Candidemia in the 21st Century
Chang, A., Neofytos, D., & Horn, D. (2008) · Future Microbiology · doi:10.2217/17460913.3.4.463 · Cited by 35
Increase in Candida parapsilosis Fungemia in Critical Care Units: A 6-Years Study
Horasan, E. Ş., Ersöz, G., GÖKSU, M., Otaǧ, F., Kurt, A., Karaçorlu, S., & Ali Hakan, K. A. Y. A. (2010) · Mycopathologia · doi:10.1007/s11046-010-9322-5 · Cited by 34
Comparative analysis of Gram's stain, PNA ‐ FISH and Sepsityper with MALDI ‐ TOF MS for the identification of yeast direct from positive blood cultures
Gorton, R., Ramnarain, P., Barker, K. R., Stone, N. R. H., Rattenbury, S., McHugh, T. D., & Kibbler, C. C. (2014) · Mycoses · doi:10.1111/myc.12205 · Cited by 34
Echinocandins Compared to Fluconazole for Candidemia of a Urinary Tract Source: A Propensity Score Analysis
Cuervo, G., García‐Vidal, C., Puig‐Asensio, M., Vena, A., Meije, Y., Fernández‐Ruiz, M., González, E. M., Blanco-Vidal, M. J., Manzur, A., Cardozo, C., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix033 · Cited by 34
Probiotics as antifungal agents: Experimental confirmation and future prospects
Kosgey, J. C., Jia, L., Fang, Y., Yang, J., Gao, L., Wang, J., Nyamao, R. M., Cheteu, M., Tong, D., Wekesa, V. W., et al. (2019) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2019.05.001 · Cited by 36
The Host Immune System Facilitates Disseminated Staphylococcus aureus Disease Due to Phagocytic Attraction to Candida albicans during Coinfection: a Case of Bait and Switch
Allison, D. L., Scheres, N., Willems, H. M. E., Bode, C. S., Krom, B. P., & Shirtliff, M. E. (2019) · Infection and Immunity · doi:10.1128/iai.00137-19 · Cited by 36
Phosphoric Metabolites Link Phosphate Import and Polysaccharide Biosynthesis for Candida albicans Cell Wall Maintenance
Liu, N., Acosta‐Zaldívar, M., Qi, W., Diray‐Arce, J., Walker, L. A., Kottom, T. J., Kelly, R., Yuan, M., Asara, J. M., Lasky-Su, J. A., et al. (2020) · mBio · doi:10.1128/mbio.03225-19 · Cited by 33
The Epidemiology of Invasive Candidiasis
Pfaller, M. A., & Diekema, D. J. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch29 · Cited by 33
Candidiasis — Do we need to fight or to tolerate theCandida fungus?
Raška, M., Běláková, J., Křupka, M., & Weigl, E. (2007) · Folia Microbiologica · doi:10.1007/bf02931313 · Cited by 33
Ten-year review of invasive Candida infections in a tertiary care center in Saudi Arabia
Omrani, A. S., Makkawy, E. A., Baig, K., Baredhwan, A. A., Almuthree, S. A., Elkhizzi, N. A., & Albarrak, A. M. (2014) · Saudi Medical Journal · doi:10.15537/1658-3175.6005 · Cited by 33
Multicenter Comparison of the Vitek 2 Antifungal Susceptibility Test with the CLSI Broth Microdilution Reference Method for Testing Caspofungin, Micafungin, and Posaconazole against Candida spp
Peterson, J. F., Pfaller, M. A., Diekema, D. J., Rinaldi, M. G., Riebe, K. M., & Ledeboer, N. A. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02517-10 · Cited by 33
Artificial intelligence-aided rapid and accurate identification of clinical fungal infections by single-cell Raman spectroscopy
Xu, J., Luo, Y., Wang, J., Tu, W., Yi, X., Xu, X., Song, Y., Tang, Y., Hua, X., Yu, Y., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1125676 · Cited by 34
Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: A multicentre observational study by the Turkish Fungal Infections Study Group
Doğan, Ö., Yesilkaya, A., Menekşe, Ş., Güler, Ö., Karakoç, Ç., Çınar, G., Kapmaz, M., Aydın, M., Keske, Ş., Şahin, S., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105992 · Cited by 32
Multilocus Sequence Typing of Candida tropicalis Shows the Presence of Different Clonal Clusters and Fluconazole Susceptibility Profiles in Sequential Isolates from Candidemia Patients in São Paulo, Brazil
Magri, M. M. C., Gomes‐Gouvêa, M. S., de Freitas, V. L. T., Motta, A. L., Moretti, M. L., & Shikanai‐Yasuda, M. A. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.02366-12 · Cited by 32
Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007.
Nace, H., Horn, D., & Neofytos, D. (2009) · Diagnostic microbiology and infectious disease · doi:10.1016/j.diagmicrobio.2009.03.010 · Cited by 35
Candidaemia in a large teaching hospital: a clinical audit
Aliyu, S. H. (2006) · QJM · doi:10.1093/qjmed/hcl087 · Cited by 31
Clinical and molecular characteristics of bloodstream infections caused by Candida albicans in children from 2003 to 2011
Tsai, M.-H., Wang, S.-H., Hsu, J., Lin, L.-C., Chu, S., Huang, H.-R., Chiang, M., Fu, R.-H., Lu, J., & Huang, Y. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.06.024 · Cited by 31
Novel amalgamation of phthalazine–quinolines as biofilm inhibitors: One-pot synthesis, biological evaluation and in silico ADME prediction with favorable metabolic fate
Zaheer, Z., Khan, F. A. K., Sangshetti, J. N., Patil, R., & Lohar, K. S. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.02.057 · Cited by 31
Bibliometric analysis of literature on antifungal triazole resistance: 1980 – 2015
Sweileh, W. M., Sawalha, A. F., Al‐Jabi, S. W., & Zyoud, S. H. (2017) · GERMS · doi:10.18683/germs.2017.1104 · Cited by 31
Economic analysis of inadequate fluconazole therapy in non-neutropenic patients with candidaemia: a multi-institutional study
Garey, K. W., Turpin, R. S., Bearden, D. T., Pai, M. P., & Suda, K. J. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.01.001 · Cited by 30
Treatment and outcomes of Candida osteomyelitis: review of 53 cases from the PATH Alliance® registry
Neofytos, D., Huprikar, S. S., Reboli, A. C., Schuster, M. G., Azie, N. E., Franks, B., & Horn, D. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1939-0 · Cited by 31
Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases
Cornely, O. A., Pappas, P. G., Young, J. H., Maddison, P., & Ullmann, A. J. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.557062 · Cited by 31
The End of an Era in Defining the Optimal Treatment of Invasive Candidiasis
Clancy, C. J., & Nguyen, M. H. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis023 · Cited by 31
Incidence, clinical characteristics, risk factors and outcomes of patients with mixed Candida/bacterial bloodstream infections: a retrospective study
Zhong, L., Dong, Z., Liu, F., Li, H., Tang, K., Zheng, C., Wang, L., Zhang, K., Cai, J., Zhou, H., et al. (2022) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-022-00538-y · Cited by 34
Recent Progress in the Diagnosis of Pathogenic Candida Species in Blood Culture
Phoompoung, P., & Chayakulkeeree, M. (2016) · Mycopathologia · doi:10.1007/s11046-016-0003-x · Cited by 30
Invasive candidiasis: future directions in non-culture based diagnosis
Posch, W., Heimdörfer, D., Wilflingseder, D., & Lass‐Flörl, C. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1370373 · Cited by 29
Identification of Antifungal Compounds against Multidrug-Resistant Candida auris Utilizing a High-Throughput Drug-Repurposing Screen
Cheng, Y., Roma, J. S., Shen, M., Fernandes, C. M., Tsang, P. S., Forbes, H. J., Boshoff, H. I., Lazzarini, C., Poeta, M. D., Zheng, W., et al. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01305-20 · Cited by 29
Candida glabrata : new tools and technologies—expanding the toolkit
Ho, H.-L., & Haynes, K. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov066 · Cited by 29
An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia
Cardozo, C., Cuervo, G., Salavert, M., Merino, P., Gioia, F., Fernández‐Ruiz, M., López-Cortés, L. E., Escolà‐Vergé, L., Montejo, M., Muñóz, P., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz491 · Cited by 29
Understand the genomic diversity and evolution of fungal pathogen Candida glabrata by genome-wide analysis of genetic variations
Guo, X., Zhang, R., Li, Y., Wang, Z., Ishchuk, O. P., Ahmad, K. M., Wee, J., Piškur, J., Shapiro, J. A., & Gu, Z. (2019) · Methods · doi:10.1016/j.ymeth.2019.05.002 · Cited by 28
Echinocandins in the treatment of candidaemia and invasive candidiasis: clinical and economic perspectives
Neoh, C. F., Slavin, M. A., Chen, S. C. ‐., Stewart, K., & Kong, D. C. M. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.08.010 · Cited by 28
Difficulties with Fungal Infections in Acute Myelogenous Leukemia Patients: Immune Enhancement Strategies
Safdar, A. (2007) · The Oncologist · doi:10.1634/theoncologist.12-s2-2 · Cited by 28
Is Fluconazole or an Echinocandin the Agent of Choice for Candidemia
Eschenauer, G. A., Nguyen, M.-H., & Clancy, C. J. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015590838 · Cited by 27
The host transcriptional response to Candidemia is dominated by neutrophil activation and heme biosynthesis and supports novel diagnostic approaches
Steinbrink, J. M., Myers, R. A., Hua, K., Johnson, M. D., Seidelman, J., Tsalik, E. L., Henao, R., Ginsburg, G. S., Woods, C. W., Alexander, B. D., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00924-9 · Cited by 28
Pharmacotherapy of yeast infections
Gómez‐López, A., Zaragoza, Ó., Rodríguez-Tudela, J. L., & Cuenca‐Estrella, M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.16.2801 · Cited by 29
Candidemia in the in-patient setting: treatment options and economics
Gagne, J. J., & Goldfarb, N. I. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.11.1643 · Cited by 27
Opportunistic invasive fungal pathogen Macrophomina phaseolina prognosis from immunocompromised humans to potential mitogenic RBL with an exceptional and novel antitumor and cytotoxic effect
Arora, P., Dilbaghi, N., & Chaudhury, A. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1275-1 · Cited by 27
A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains
Cuervo, G., Puig‐Asensio, M., García‐Vidal, C., Fernández‐Ruiz, M., Pemán, J., Nucci, M., Aguado, J. M., Salavert, M., González‐Romo, F., Guinea, J., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.02.029 · Cited by 26
Clinical Characteristics and Risk Factors for Nosocomial Candidemia in Medical Intensive Care Units: Experience in a Single Hospital in Korea for 6.6 Years
Han, S., Yim, J., Yoo, C., Kim, Y. W., Han, S. K., Shim, Y.-S., & Lee, S. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.5.671 · Cited by 26
Patient isolation measures for infants with candida colonization or infection for preventing or reducing transmission of candida in neonatal units
Pammi, M., Eddama, O., & Weisman, L. E. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006068.pub3 · Cited by 25
Itraconazole-Loaded Ufasomes: Evaluation, Characterization, and Anti-Fungal Activity against Candida albicans
Hashem, S. M., Gad, M. K., Anwar, H. M., Saleh, N. M., Shamma, R. N., & Elsherif, N. I. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics15010026 · Cited by 27
Improving patient care through implementation of an antimicrobial stewardship program
Palmer, H. R., Weston, J. S., Gentry, L. O., Salazar, M. J., Putney, K. S., Frost, C. P., Tipton, J. A., Cottreau, J. M., Tam, V. H., & Garey, K. W. (2011) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp100635 · Cited by 24
Épidémiologie des candidémies : étude observationnelle prospective d’un an dans l’Ouest de la France
Talarmin, J. P., Boutoille, D., Tattevin, P., Dargère, S., Weinbreck, P., Ansart, S., Chennebault, J. M., Hutin, P., Leautez-Nainville, S., Gay‐Andrieu, F., et al. (2009) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2009.02.008 · Cited by 24
Invasive candidiasis in the ICU: evidence based and on the edge of evidence
Hollenbach, E. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01571.x · Cited by 24
Nucleic-Acid-Based Molecular Fungal Diagnostics: A Way to a Better Future
Gudisa, R., Harchand, R., & Rudramurthy, S. M. (2024) · Diagnostics · doi:10.3390/diagnostics14050520 · Cited by 24
Antimicrobial Activity and Gas Chromatography-Mass Spectrometry (GC-MS) Analysis of Saudi Arabian Ocimum basilicum Leaves Extracts
Ababutain, I. M. (2019) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.13.2.17 · Cited by 23
Impact of Initial Antifungal Therapy on the Outcome of Patients With Candidemia and Septic Shock Admitted to Medical Wards: A Propensity Score–Adjusted Analysis
Falcone, M., Tiseo, G., Gutiérrez‐Gutiérrez, B., Raponi, G., Carfagna, P., Rosin, C., Luzzati, R., Rose, D. D., Andreoni, M., Farcomeni, A., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz251 · Cited by 24
Evolving role of early antifungals in the adult intensive care unit
Lam, S. W., Eschenauer, G. A., & Carver, P. L. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819dec9b · Cited by 23
A prospective analysis of the genotypic diversity and dynamics of the Candida albicans colonizing flora in neutropenic patients with de novo acute leukemia
Dalle, F., Lafon, I., L’Ollivier, C., Ferrant, E., Sicard, P., Labruère, C., Jébrane, A., Laubriet, A., Vagner, O., Caillot, D., et al. (2008) · Haematologica · doi:10.3324/haematol.11882 · Cited by 23
Ibuprofen-Mediated Reversal of Fluconazole Resistance in Clinical Isolates of Candida
Sharma, M. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/10094.5494 · Cited by 24
Evaluation of Biomarkers: Galactomannan and 1,3-Beta-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections in Immunocompromised Patients from a Tertiary Care Centre
Singh, S., Kaur, H., Choudhary, H., Sethi, S., Malhotra, P., Gupta, K. L., Rudramurthy, S. M., & Chakrabarti, A. (2018) · Indian Journal of Medical Microbiology · doi:10.4103/ijmm.ijmm_18_366 · Cited by 22
Candida spp. and phagocytosis: multiple evasion mechanisms
Oliver, J. C., Ferreira, C. B. R. J., Silva, N. C., & Dias, A. L. T. (2019) · Antonie van Leeuwenhoek · doi:10.1007/s10482-019-01271-x · Cited by 24
Anti-Candida activity of ethanolic extracts of Iranian endemic medicinal herbs against Candida albicans
Boroujeni, H. R. (2012) · Journal of Medicinal Plants Research · doi:10.5897/jmpr11.1550 · Cited by 23
In vitro potency and fungicidal activity of CD101, a novel echinocandin, against recent clinical isolates of Candida spp.
Hall, D., Bonifas, R., Stapert, L., Thwaites, M., Shinabarger, D. L., & Pillar, C. M. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.07.007 · Cited by 22
Candidaemia in the non-neutropenic patient: A critique of the guidelines
Deshpande, A., Gaur, S., & Bal, A. M. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.06.005 · Cited by 24
Treatment of invasive candidiasis with echinocandins
Glöckner, A., Steinbach, A., Vehreschild, J. J., & Cornely, O. A. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01645.x · Cited by 22
Infección fúngica invasora en el paciente crítico: diferentes opciones terapéuticas y una misma estrategia
Zaragoza, R., & Pemán, J. (2006) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(06)70014-6 · Cited by 22
Polymerase Chain Reaction Versus Blood Culture to Detect Candida Species in High-Risk Patients with Suspected Invasive Candidiasis: The MICAFEM Study
Nieto, M., Robles, J. C., Causse, M., Gutiérrez, L., Perez, M. C., Ferrer, R., Xercavins, M., Herrero, E., Sirvent, E., Fernández, C., et al. (2019) · Infectious Diseases and Therapy · doi:10.1007/s40121-019-0248-z · Cited by 22

Authors: Morgan, J., Meltzer, M. I., Plikaytis, B. D., Sofair, A. N., Huie-White, S., Wilcox, S., Harrison, L. H., Seaberg, E. C., Hajjeh, R. A., & Teutsch, S. M.
Affiliations: Centers for Disease Control and Prevention (US)
Johns Hopkins University (US)
Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
Corresponding author: Morgan, Juliette
ORCID: Morgan, Juliette
Meltzer, Martin I.
Harrison, Lee H.
Seaberg, Eric C.
Hajjeh, Rana A.
Teutsch, Steven M.
Venue: Infection Control & Hospital Epidemiology
Publisher: Cambridge University Press (CUP)
Published: 2005-06
Volume: 26
Issue: 6
Pages: 540-547
ISSN: 0899-823X (ISSN-L)
1559-6834
DOI: 10.1086/502581
OpenAlex: W2138648278
Semantic Scholar: fbb5a839e0dc3b43795b4bba8e920640a069b23b
Cited by: 437
References: 26
Citations by year: 2026: 9 · 2025: 13 · 2024: 16 · 2023: 15 · 2022: 18 · 2021: 15 · 2020: 21 · 2019: 24 · 2018: 10 · 2017: 19 · 2016: 24 · 2015: 27 · 2014: 18 · 2013: 26 · 2012: 36
FWCI: 11.94
Type: journal article
Language: en
Open access: closed
Licence: www.cambridge.org/core/terms (unspecified, 4038 d)
Locations: Infection Control and Hospital Epidemiology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
Keywords: candidemia, excess mortality, length of hospital stay, hospital costs, fungemia, Connecticut, Baltimore
MeSH terms: Adolescent, Adult, Candidiasis, Child, Child, Preschool, Connecticut, Cross Infection, Female, Humans, Infant, Length of Stay, Male, Middle Aged, Population Surveillance, Baltimore, Multivariate Analysis, Linear Models, Case-Control Studies, Fungemia, Hospital Mortality, Cost of Illness, Age Distribution, Hospital Costs, Hospital Charges

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Excess Mortality, Hospital Stay, and Cost Due to Candidemia: A Case-Control Study Using Data From Population-Based Candidemia Surveillance

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks